[{"address1": "2222 Ponce de Leon Boulevard", "address2": "Floor 3", "city": "Coral Gables", "state": "FL", "zip": "33134", "country": "United States", "phone": "786 629 1376", "website": "https://www.relmada.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system diseases (CNS) and other disorders in the United States. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a N-methyl-D-aspartate receptor antagonist which is in phase 3 clinical trial for the adjunctive or monotherapy treatment of major depressive disorder. The company is headquartered in Coral Gables, Florida.", "fullTimeEmployees": 20, "companyOfficers": [{"maxAge": 1, "name": "Dr. Sergio  Traversa M.B.A., Pharm.D.", "age": 64, "title": "CEO & Director", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 1788492, "exercisedValue": 0, "unexercisedValue": 299675}, {"maxAge": 1, "name": "Mr. Maged S. Shenouda M.B.A., R.Ph.", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 1007410, "exercisedValue": 0, "unexercisedValue": 198021}, {"maxAge": 1, "name": "Mr. Paul E. Kelly M.B.A.", "age": 67, "title": "COO & Director", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 600000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gina  DiGuglielmo", "title": "VP & Head of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Hixon", "title": "Head of Commercial", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew  Cutler", "title": "Senior Clinical Development Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Richard M. Mangano Ph.D.", "age": 74, "title": "Consultant", "yearBorn": 1950, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 4, "overallRisk": 8, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.2729, "open": 0.2686, "dayLow": 0.264, "dayHigh": 0.2926, "regularMarketPreviousClose": 0.2729, "regularMarketOpen": 0.2686, "regularMarketDayLow": 0.264, "regularMarketDayHigh": 0.2926, "payoutRatio": 0.0, "beta": 0.646, "forwardPE": -0.14253731, "volume": 524082, "regularMarketVolume": 524082, "averageVolume": 1297569, "averageVolume10days": 414590, "averageDailyVolume10Day": 414590, "bid": 0.2022, "ask": 0.351, "bidSize": 2, "askSize": 2, "marketCap": 8644909, "fiftyTwoWeekLow": 0.24, "fiftyTwoWeekHigh": 6.38, "fiftyDayAverage": 0.35544, "twoHundredDayAverage": 2.332715, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -45472820, "profitMargins": 0.0, "floatShares": 27550555, "sharesOutstanding": 30174200, "sharesShort": 1746824, "sharesShortPriorMonth": 1250383, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0579, "heldPercentInsiders": 0.080369994, "heldPercentInstitutions": 0.29821, "shortRatio": 0.97, "shortPercentOfFloat": 0.0589, "impliedSharesOutstanding": 30174200, "bookValue": 1.578, "priceToBook": 0.18155895, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -86487376, "trailingEps": -2.86, "forwardEps": -2.01, "lastSplitFactor": "1:4", "lastSplitDate": 1569801600, "52WeekChange": -0.9526863, "SandP52WeekChange": 0.121255875, "quoteType": "EQUITY", "currentPrice": 0.2865, "targetHighPrice": 1.0, "targetLowPrice": 0.6, "targetMeanPrice": 0.86667, "targetMedianPrice": 1.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 54117728, "totalCashPerShare": 1.794, "totalDebt": 0, "quickRatio": 6.692, "currentRatio": 6.888, "returnOnAssets": -0.69481003, "returnOnEquity": -1.16598, "freeCashflow": -23012032, "operatingCashflow": -53205880, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "RLMD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 4.9835186, "regularMarketPrice": 0.2865, "corporateActions": [], "postMarketTime": 1741391947, "regularMarketTime": 1741381201, "exchange": "NMS", "messageBoardId": "finmb_9070579", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Relmada Therapeutics, Inc.", "longName": "Relmada Therapeutics, Inc.", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1403271000000, "postMarketChangePercent": -3.97906, "postMarketPrice": 0.2751, "postMarketChange": -0.0114, "regularMarketChange": 0.013600022, "regularMarketDayRange": "0.264 - 0.2926", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1297569, "fiftyTwoWeekLowChange": 0.046500012, "fiftyTwoWeekLowChangePercent": 0.19375005, "fiftyTwoWeekRange": "0.24 - 6.38", "fiftyTwoWeekHighChange": -6.0935, "fiftyTwoWeekHighChangePercent": -0.95509404, "fiftyTwoWeekChangePercent": -95.26863, "dividendDate": 1569801600, "earningsTimestampStart": 1742241600, "earningsTimestampEnd": 1742587200, "earningsCallTimestampStart": 1731015000, "earningsCallTimestampEnd": 1731015000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.86, "epsForward": -2.01, "epsCurrentYear": -1.72, "priceEpsCurrentYear": -0.16656977, "fiftyDayAverageChange": -0.068939984, "fiftyDayAverageChangePercent": -0.19395675, "twoHundredDayAverageChange": -2.046215, "twoHundredDayAverageChangePercent": -0.87718177, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Relmada Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]